共 50 条
- [43] The non-small-cell lung cancer drug market [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (04) : 229 - 230
- [44] BRAF Mutations in Non-Small-Cell Lung Cancer [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1594 - 1595
- [45] Antiangiogenic therapies in non-small-cell lung cancer [J]. CURRENT ONCOLOGY, 2018, 25 : S45 - S58
- [46] Preoperative chemotherapy for non-small-cell lung cancer [J]. LANCET, 2014, 384 (9939): : 232 - 233
- [47] Advanced Non-Small-Cell Lung Cancer in the Elderly [J]. CLINICAL LUNG CANCER, 2009, 10 (03) : 158 - 167
- [48] Gefitinib for the treatment of non-small-cell lung cancer [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1343 - 1357
- [50] Adagrasib in Non-Small-Cell Lung Cancer REPLY [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (13): : 1239 - 1239